Currently, there are 754.00M common shares owned by the public and among those 700.22M shares have been available to trade.
Insiders at the company have transacted a total of 106 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 47 of these insider trades were purchases, accounting for 14,801,683 shares. Insider sales of the common stock occurred on 59 occasions, with total insider shares sold totaling 8,296,895 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 3.3450, up 5.81%. The company’s stock has a 5-day price change of 0.61% and 82.22% over the past three months. AUR shares are trading -24.94% year to date (YTD), with the 12-month market performance up to 152.31% higher. It has a 12-month low price of $1.14 and touched a high of $4.81 over the same period. AUR has an average intraday trading volume of 6.93 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -11.09%, 10.10%, and 32.01% respectively.
Institutional ownership of Aurora Innovation Inc (NASDAQ: AUR) shares accounts for 39.64% of the company’s 754.00M shares outstanding.
It has a market capitalization of $4.98B and a beta (3y monthly) value of 3.07. The earnings-per-share (ttm) stands at -$0.74. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.20% over the week and 7.99% over the month.
Analysts forecast that Aurora Innovation Inc (AUR) will achieve an EPS of $Aurora Cannabis Inc. for the current quarter, $0.42 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Aurinia Pharmaceuticals Inc while analysts give the company a high EPS estimate of $ARMOUR Residential REIT, Inc.. Comparatively, EPS for the current quarter was $Alpha Metallurgical Resources, a year ago. Earnings per share for the fiscal year are expected to increase by 57.95%, and 9.84% over the next financial year.
Looking at the support for the AUR, a number of firms have released research notes about the stock. Goldman stated their Sell rating for the stock in a research note on January 03, 2024, with the firm’s price target at $1.75-$2.
